Biotechnology in healthcare. Volume 2, Applications and regulatory issues / edited by Debmalya Barh.

Format:

• Book

Contributor:

• Barh, Debmalya, editor.

Language:

English

Subjects (All):

• Biotechnology.
• Medical technology.

Genre:

• Electronic books.

Physical Description:

1 online resource (xix, 367 pages)

Other Title:

Applications and regulatory issues

Place of Publication:

London, UK : Academic Press, [2022]

Contents:

• Front Cover
• Biotechnology in Healthcare, Volume 2
• Biotechnology in Healthcare, Volume 2: Applications and Initiatives
• Copyright
• Dedication
• Contents
• Contributors
• About editor
• Preface
• 1
• Applications of biotechnology in healthcare
• Biotechnology in primary healthcare and hospital management
• 1. Introduction
• 2. Primary healthcare and its importance: current status in India
• 3. Biotechnology applications in primary healthcare
• 3.1 Diagnosis
• 3.2 Treatment
• 3.3 Preventives
• 3.4 Family planning and family medicine
• 4. Biotechnology in hospital management
• 4.1 Sterilization and operation theater
• 4.2 Rapid and mass molecular diagnosis
• 4.2.1 Genetic diseases, disorders, and molecular diagnosis
• 4.3 Targeted therapy
• 4.3.1 Prostate carcinoma and targeted therapy
• 4.3.2 Breast cancer and targeted therapy
• 4.3.3 Lung cancer and targeted therapy
• 4.4 Probiotic and biome replacement therapy
• 4.5 In transfusion medicine
• 5. Biotechnology-based biosafety
• 6. Challenges and future prospects
• Acknowledgments
• References
• 2
• Biotechnology in public and rural health
• 1. Introduction
• 2. Biotechnology approaches to improve public and rural health
• 2.1 Vaccines and delivery of vaccines
• 2.2 Nutrients enriched genetically modified food
• 2.3 Reduced food toxins and allergens
• 2.4 Life-saving vaccines
• 3. Advanced biotechnological achievements applied in rural areas
• 4. Environmental biotechnology applied to public and rural health
• 5. Future prospects
• 3
• Invertebrate models in translational research: lessons from Caenorhabditis elegans and Drosophila melanogaster
• 2. Caenorhabditis elegans models for translational research
• 2.1 Aging
• 2.2 Cancer
• 2.3 Rare human disease
• 2.4 Neurological and movement disorders
• 2.4.1 Alzheimer disease
• 2.4.2 Parkinson disease
• 2.4.3 Amyotrophic lateral sclerosis
• 2.5 Obesity
• 3. Drosophila models for translational research
• 3.1 Aging
• 3.2 Cancer
• 3.3 Modeling rare human diseases
• 3.4 Neurological and movement disorders
• 3.4.1 Alzheimer disease
• 3.4.2 Parkinson disease
• 3.4.3 Amyotrophic lateral sclerosis
• 3.5 Obesity
• 4. Translational impact of invertebrate research
• Glossary
• References
• 4
• Biotechnology for diagnosis, prognosis, and monitoring cancer
• 1.1 Limitations and advantages of tissue biopsy
• 1.2 Limitations and advantages of liquid biopsy
• 2. Types of liquid biopsy specimens
• 2.1 Circulating tumor cells
• 2.1.1 Preanalytical considerations
• 2.2 Extracellular vesicles (exosomes)
• 2.2.1 Preanalytical considerations
• 2.3 Circulating RNAs
• 2.3.1 Preanalytical considerations
• 2.4 Circulating free DNA
• 2.4.1 Preanalytical considerations
• 3. Chemical modifications to increase sensitivity in mutant detection
• 3.1 LNA-PCR
• 3.2 PNA-PCR

Notes:

Description based on online resource; title from PDF title page (Elsevier, viewed August 31, 2022).

ISBN:

• 9780323903646
• 0323903649

OCLC:

1341330031

Access Restriction:

Restricted for use by site license.